维生素D和过敏性鼻炎:一个迷你回顾
1Medical Faculty, Sakarya University, Adapazarı 54100, Sakarya, Türkiye.
World journal of methodology
|March 11, 2026
概括
维生素D可能在过敏性鼻炎 (AR) 严重程度方面发挥作用. 虽然一些研究将低维生素D与更糟糕的AR联系起来,但对AR维生素D补充剂的研究显示出混合的结果,需要更多的试验.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏学 过敏学
- 内分泌学 在内分泌学.
背景情况:
- 过敏性鼻炎 (AR) 是一种普遍的炎症状况,影响全球健康.
- 维生素D是一种免疫调节激素,正在研究其对AR等过敏性疾病的影响.
- 观察性研究表明,血清25-基维生素D的低水平与AR患病率的增加之间存在相关性,特别是在儿童和男性中.
研究的目的:
- 综合目前关于维生素D水平与过敏性鼻炎之间的关系的证据.
- 探索流行病学发现和免疫学机制,将维生素D和AR联系起来.
- 评估维生素D作为AR辅助疗法的潜力.
主要方法:
- 对维生素D和AR患病率的流行病学研究的审查.
- 对维生素D对免疫反应的影响免疫机制的分析.
- 对AR治疗维生素D补充剂的干预研究的评估.
主要成果:
- 观察数据表明,较低的维生素D水平与较高的AR风险/严重程度之间存在联系.
- 对AR维生素D补充剂的干预研究产生了不一致的结果.
- 维生素D的潜在益处可能取决于个人因素,如基线水平,性别和年龄.
结论:
- 新出现的证据表明,维生素D缺乏可能会使AR恶化,但其治疗作用尚未确定.
- 需要进一步进行高质量的随机对照试验,以澄清机制并指导临床实践.
- 需要个性化的治疗策略,考虑患者的个人资料,以获得最佳的AR维生素D治疗.
相关概念视频
Allergic Reactions: Anaphylaxis
103
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
103
Allergic Reactions
33.2K
Overview
33.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.1K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.1K
Drugs Used in Lower Respiratory Disorders: Overview
1.4K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.4K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
Allergic Drug Reactions
1.5K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.5K


